Skip to content

Anivance

Plug and Play · Drug development solution, Paitent on chips

Competitors

Adjacent

Also from Plug and Play in AI

All of Plug and Play

Programs

Programs Anivance went through
ProgramCohortSource
Plug and PlayNot statedPlug and Play Page

About Anivance

Anivance AI is transforming preclinical research with an end-to-end platform aligned with the U.S. FDA’s 2025 roadmap for New Approach Methodologies (NAMs). By replacing traditional animal testing with scalable, predictive, and ethically sound technologies, we accelerate safer, faster drug development. Our integrated system combines organ-on-chip modeling, high-throughput phenotypic profiling, and predictive AI to deliver actionable insights in oncology, rare diseases, and advanced drug delivery. With 25 patents and partnerships across 50+ physicians and six clinical institutions, Anivance AI is backed by Taiwan’s largest public tech firms and was nominated for the LUSH Prize in Science. We pioneer a “No Animals, No Delays, Just Human Data” vision.

Category
AI
Location
Taiwan
Checked
3h ago

Anivance: questions

Which accelerators did Anivance go through?

Anivance is listed by Plug and Play.

Where is Anivance based?

Anivance lists Taiwan as its location on Plug and Play's page.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.